Leiomyosarcoma – Basic Information

Go back

Leiomyosarcoma is a rare and aggressive type of cancer that originates in the smooth muscles found throughout the body. This disease, which accounts for up to one-fifth of all soft tissue sarcomas, can develop in hollow organs like the uterus, stomach, intestines, bladder, or even in blood vessels. Because symptoms often don’t appear until the disease is advanced, early detection and treatment are essential for improving the chances of recovery.

Understanding How Common Leiomyosarcoma Is

Leiomyosarcoma is considered a rare cancer. In the United States, approximately 15,000 people are diagnosed with soft tissue sarcomas every year, and leiomyosarcoma represents about 10% to 20% of these cases. This means that roughly 1 in every 100,000 people in the United States will develop this type of cancer.[1][3]

The disease can affect anyone, regardless of age or gender. However, it is most commonly diagnosed in females, particularly those over the age of 50. While leiomyosarcoma is rare in children, when it does occur in younger populations, it typically appears in the gastrointestinal tract, which includes the stomach, intestines, and related organs.[1][6]

The rarity of leiomyosarcoma presents unique challenges. Because there are fewer cases to study compared to more common cancers, researchers have less data to work with when developing new treatments. Additionally, the disease encompasses approximately 70 different subtypes of sarcomas, making it difficult to conduct large clinical trials that produce meaningful results. This has historically led to studies that group many different sarcoma types together, even though research now indicates that different subtypes may respond differently to various treatments.[11]

What Causes This Type of Cancer

The exact cause of leiomyosarcoma remains largely unknown to medical researchers. What scientists do understand is that the disease can develop in two primary ways: either through inherited genetic changes passed down from parents, or through genetic mutations that occur during a person’s lifetime. These genetic alterations cause normal smooth muscle cells to grow uncontrollably, eventually forming cancerous tumors.[1]

Leiomyosarcoma originates from smooth muscle cells or their precursor cells, known as mesenchymal cells (cells that can develop into various types of connective tissue). These smooth muscles are found in many parts of the body, including the walls of hollow organs and blood vessels. Because smooth muscles are so widespread, leiomyosarcoma can theoretically develop almost anywhere in the body, though it most commonly appears in the retroperitoneum (the area behind the intestines), the uterus, and the extremities.[3][8]

The genetic abnormalities associated with leiomyosarcoma are complex and not fully understood. The disease is characterized by what scientists call complex karyotypes (the complete set of chromosomes in a cell), suggesting that genomic instability—meaning the genetic material within cells is prone to changes and mutations—might be a driving force behind the cancer’s development.[4]

Risk Factors That Increase Your Chances

While the precise cause of leiomyosarcoma is unclear, researchers have identified several factors that appear to increase a person’s risk of developing this cancer. Understanding these risk factors can help individuals and healthcare providers stay vigilant for early signs of the disease.

One of the most significant risk factors is a history of radiation exposure, particularly radiation therapy received at a young age. People who have undergone radiation treatment for other cancers may have an elevated risk of developing soft tissue sarcomas, including leiomyosarcoma, later in life.[3][8]

Certain inherited genetic conditions are also linked to an increased risk of leiomyosarcoma. These conditions include Gardner syndrome, Gorlin syndrome, hereditary retinoblastoma, Li-Fraumeni syndrome (caused by mutations in the TP53 gene), neurofibromatosis type 1, tuberous sclerosis, and Werner syndrome. People with these genetic syndromes should discuss their cancer risk with their healthcare providers and consider regular screening.[1][3]

Additionally, there appears to be a connection between leiomyosarcoma and certain viral infections. Studies have shown a possible link between the disease and Epstein-Barr virus infection, which is also known as the virus that causes mononucleosis or “mono.” Furthermore, individuals with compromised immune systems—such as those with HIV, AIDS, or those taking immunosuppressive medications—may be more vulnerable to developing leiomyosarcoma.[6]

⚠️ Important
If you have a family history of the genetic conditions mentioned above or have received radiation therapy in the past, it’s important to discuss your risk with a healthcare provider. While having a risk factor doesn’t mean you will definitely develop leiomyosarcoma, being aware allows for early detection if the disease does develop.

Recognizing the Symptoms

One of the most challenging aspects of leiomyosarcoma is that many people don’t experience noticeable symptoms in the early stages of the disease. This is partly because soft tissue is elastic and can be easily moved aside as a tumor grows, allowing the cancer to exist for some time before being discovered. Symptoms often only become apparent as the tumor grows larger or begins to affect surrounding tissues and organs.[1][6]

When symptoms do appear, they vary greatly depending on where the tumor is located in the body and how large it has grown. Some of the most common general symptoms include a firm, painless lump that can be felt under the skin, unexplained weight loss, persistent tiredness, fever, and nausea or vomiting. Some people may also experience pain as the tumor grows and begins to compress nearby nerves or muscles.[1]

If the leiomyosarcoma develops in the digestive system, individuals may notice abdominal pain, abdominal bloating, loss of appetite, nausea and vomiting, or black stools caused by bleeding in the digestive tract. These symptoms can sometimes be mistaken for other, more common digestive conditions, which can delay proper diagnosis.[1]

Uterine leiomyosarcoma, which affects the muscle tissue of the uterus, can cause abnormal uterine bleeding, vaginal discharge, and frequent urination as the tumor grows and presses on the bladder. For individuals with tumors in the extremities, symptoms might include limping or difficulty using the affected limb.[1][6]

Because soft tissue sarcomas can develop over a long period without causing obvious symptoms, any persistent, unexplained lumps, pain, or other unusual changes in your body should be evaluated by a healthcare professional. Early detection significantly improves the chances of successful treatment.

How Leiomyosarcoma Is Prevented

Because the exact cause of leiomyosarcoma is not fully understood, there are no guaranteed ways to prevent the disease. However, understanding your risk factors and taking certain precautions may help reduce your chances of developing this cancer or catch it early when treatment is most effective.

For individuals with known genetic conditions that increase cancer risk, regular monitoring and genetic counseling are important. If you have a family history of conditions like Li-Fraumeni syndrome, hereditary retinoblastoma, or other genetic syndromes linked to leiomyosarcoma, talk to your healthcare provider about appropriate screening schedules and preventive measures.[1]

Minimizing unnecessary radiation exposure is another important consideration. While radiation therapy is sometimes necessary for treating other cancers, the decision to use radiation should always involve careful consideration of the benefits versus the long-term risks, including the potential for developing secondary cancers like leiomyosarcoma later in life.[3]

Maintaining overall health through a balanced diet, regular exercise, and avoiding tobacco may contribute to a stronger immune system and better overall cancer prevention, though these measures have not been specifically proven to prevent leiomyosarcoma. Some research suggests that certain foods may have anti-cancer properties, including cruciferous vegetables like broccoli and cauliflower, which contain compounds that may help reduce tumor size, though more research is needed in this area.[17]

Regular medical checkups and being attentive to changes in your body remain the most practical approaches to early detection. If you notice any unusual lumps, persistent pain, unexplained weight loss, or other concerning symptoms, seek medical attention promptly. Early-stage leiomyosarcoma is much more treatable than advanced disease.

What Happens in Your Body

Understanding what happens in the body when leiomyosarcoma develops can help patients and their families grasp the nature of this disease. Leiomyosarcoma fundamentally disrupts the normal function of smooth muscle tissue, which plays vital roles throughout the body.

Smooth muscles are involuntary muscles, meaning they work automatically without conscious control. They’re found in the walls of hollow organs like the stomach, intestines, bladder, and uterus, as well as in blood vessels throughout the body. These muscles help organs contract and move substances through the body—for example, they help move food through the digestive tract and regulate blood flow by constricting or relaxing blood vessel walls.[1]

When leiomyosarcoma develops, normal smooth muscle cells undergo genetic changes that cause them to multiply uncontrollably. Instead of following the body’s normal signals for growth and division, these cells continue to divide, forming a mass of abnormal tissue called a tumor. These tumors are characterized by several abnormal features when examined under a microscope, including pleomorphism (variation in the size and shape of cells), numerous abnormal cell divisions (mitotic figures), and areas of dead tissue called necrosis.[4]

Leiomyosarcoma is particularly aggressive and grows rapidly—the cancer can actually double in size in as little as one month. This rapid growth means the tumor can quickly become large enough to cause symptoms or spread to other parts of the body. The cancer cells travel through the bloodstream, which allows them to spread to virtually any soft tissue in the body. This process of cancer spreading is called metastasis, and it significantly complicates treatment.[1]

The tumors themselves are typically soft and hemorrhagic, meaning they contain areas of bleeding. When surgeons examine removed tumors, they often find they contain multiple areas of dead tissue and blood. The complex genetic changes in leiomyosarcoma cells make them resistant to many traditional treatments, which is why this cancer is particularly challenging to treat once it has spread beyond its original location.[4]

As the tumor grows in its original location, it begins to compress and displace surrounding healthy tissue. This mechanical pressure on neighboring structures causes many of the symptoms people experience. For example, a tumor in the abdomen might press on the intestines, causing digestive symptoms, or a tumor in the uterus might press on the bladder, causing urinary symptoms. Eventually, if left untreated, the tumor can damage organs and interfere with their normal function, leading to serious health complications.[1]

⚠️ Important
Leiomyosarcoma can spread through the bloodstream to other parts of the body, with the lungs being a common site for metastasis. This is why regular monitoring even after successful treatment is essential—the cancer can recur months or even years after initial treatment. Staying vigilant with follow-up scans can help detect any recurrence early when it’s most treatable.

Ongoing Clinical Trials on Leiomyosarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated drugs:
    Germany
  • Study Comparing Trabectedin and Gemcitabine for Patients with Advanced or Metastatic Leiomyosarcoma After Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma

    Recruiting

    3 1 1 1
    Cyprus Czechia Denmark France Germany Italy +4

References

https://my.clevelandclinic.org/health/diseases/22059-leiomyosarcoma

https://www.mdanderson.org/cancerwise/leiomyosarcoma–7-facts-about-this-rare-soft-tissue-cancer.h00-159536589.html

https://www.ncbi.nlm.nih.gov/books/NBK551667/

https://en.wikipedia.org/wiki/Leiomyosarcoma

https://www.leiomyosarcoma.org/

https://www.childrenshospital.org/conditions/leiomyosarcoma

https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/types/leiomyosarcoma

https://www.ncbi.nlm.nih.gov/books/NBK551667/

https://my.clevelandclinic.org/health/diseases/22059-leiomyosarcoma

https://www.mayoclinic.org/diseases-conditions/leiomyosarcoma/diagnosis-treatment/drc-20577224

https://www.cancer.gov/news-events/cancer-currents-blog/2024/leiomyosarcoma-yondelis-doxorubicin-improve-survival

https://www.macmillan.org.uk/cancer-information-and-support/soft-tissue-sarcoma/leiomyosarcoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC10031121/

https://www.lmsdr.org/blog/top-tips-for-newly-diagnosed-with-leiomyosarcoma

https://www.mdanderson.org/cancerwise/stage-iv-leiomyosarcoma-survivor–faith-and-quality-care-got-me-through-cancer-treatment.h00-159701490.html

https://my.clevelandclinic.org/health/diseases/22059-leiomyosarcoma

https://www.leiomyosarcoma.org/blog/06/29/15/healthy-diet-and-leiomyosarcoma/

https://www.aacr.org/patients-caregivers/survivor-journeys/nancy-mcguire-leiomyosarcoma/

https://www.mayoclinic.org/diseases-conditions/leiomyosarcoma/diagnosis-treatment/drc-20577224

https://www.macmillan.org.uk/cancer-information-and-support/soft-tissue-sarcoma/leiomyosarcoma

FAQ

Can leiomyosarcoma be cured?

When leiomyosarcoma is detected early and the tumor can be completely removed surgically with clear margins, recovery is possible. The outlook is more favorable when the cancer is caught before it spreads to other parts of the body. However, more than half of all patients treated for leiomyosarcoma require additional treatments within 8 to 16 months after initial diagnosis, and the cancer can recur even many years after being in remission.

How is leiomyosarcoma different from benign fibroids?

Leiomyosarcoma is a malignant (cancerous) tumor that grows aggressively and can spread to other parts of the body. In contrast, leiomyomas (commonly called fibroids) are benign (non-cancerous) growths that also develop from smooth muscle tissue but do not spread. However, it can be difficult to distinguish between the two before surgery, which is why proper tissue analysis is essential.

Why is leiomyosarcoma so hard to treat?

Leiomyosarcomas are resistant cancers that generally don’t respond well to chemotherapy or radiation alone. The cancer has complex genetic abnormalities that make it resistant to many traditional treatments. Additionally, symptoms often don’t appear until the disease is advanced, making early detection difficult. The best outcomes occur when the tumor can be removed surgically while it’s still small and hasn’t spread.

How often should I be monitored after treatment?

Regular surveillance with scans is essential because leiomyosarcoma can recur many years after being in remission or showing no evidence of disease. Your oncologist will recommend a specific monitoring schedule based on your individual situation, but staying up-to-date with routine scans is crucial for catching any recurrence early when it’s most treatable.

Are there clinical trials available for leiomyosarcoma?

Yes, clinical trials are ongoing and are an important option to consider, preferably before agreeing to standard treatments. Many trials combine older chemotherapy drugs with new targeted medications. However, if you’ve already received certain standard chemotherapy treatments, it may disqualify you from some trials. Participating in trials also helps advance treatment options for all leiomyosarcoma patients.

🎯 Key takeaways

  • Leiomyosarcoma is a rare, aggressive cancer that can grow remarkably fast—doubling in size in just one month.
  • About 1 in every 100,000 people in the United States develops this cancer, making it a truly rare disease.
  • The disease often goes unnoticed in early stages because symptoms typically don’t appear until the tumor is advanced.
  • Surgery remains the most effective treatment when the cancer is caught early and can be completely removed.
  • Previous radiation therapy and certain inherited genetic conditions significantly increase your risk of developing leiomyosarcoma.
  • The cancer can spread through the bloodstream to any soft tissue in the body, making long-term monitoring essential.
  • Treatment at specialized sarcoma centers with high-volume experience improves patient outcomes significantly.
  • Leiomyosarcoma can recur even many years after successful treatment, so lifelong surveillance is necessary.